Catalyst Wire Dossier Catalyst Wire Dossier

GEN-725 Tablets

GEN-725 · Henan Genuine Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN-725 Tablets, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors [Phase 1]

See pricing